Neutral Displacement Needles Market Global Report 2026

The neutral displacement needles market size has grown strongly in recent years. It will grow from $0.28 billion in 2025 to $0.3 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing adoption of intravenous therapy procedures, rising focus on reducing healthcare associated infections, growing demand for safer needle-free medical access solutions, expanding hospital infrastructure and infusion care facilities, increasing awareness of patient safety practices in healthcare settings.

The neutral displacement needles market size is expected to see strong growth in the next few years. It will grow to $0.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for advanced closed system drug delivery solutions, increasing adoption of infection control technologies in healthcare facilities, growing preference for efficient fluid management devices, expanding use of home infusion therapy services, increasing investment in next-generation medical access device development. Major trends in the forecast period include increasing adoption of closed system neutral displacement devices for improved infection prevention, growing demand for advanced fluid control solutions in intravenous therapy applications, rising preference for needle-free access devices to enhance healthcare worker safety, increasing focus on improved reflux prevention and fluid stability during medical procedures, growing development of biocompatible materials for safer and more reliable medical access devices.

The increasing focus on preventing catheter-related bloodstream infections (CRBSIs) is expected to drive the growth of the neutral displacement needles market in the coming years. A catheter-related bloodstream infection is a laboratory-confirmed bloodstream infection that occurs in a patient with a central venous catheter in place, where no other identifiable source of infection is present. Catheter-related bloodstream infections are increasing due to the growing use of vascular catheters among critically ill and chronically ill patients, extended hospital stays, the rising number of invasive procedures, and the growing occurrence of antimicrobial-resistant pathogens. Neutral displacement needles help prevent catheter-related bloodstream infections by reducing blood reflux and limiting microbial contamination at the catheter hub during intravenous access, thereby decreasing the risk of infections in clinical environments. For instance, in February 2026, according to the UK Health Security Agency, a UK government health body, catheter-associated bloodstream infections represented 21.2% of all intensive care unit-associated bloodstream infections in adult units during the financial year 2024 to 2025 (312 out of 1,474 cases). Therefore, the increasing emphasis on preventing catheter-related bloodstream infections (CRBSIs) is contributing to the growth of the neutral displacement needles market.

The rising incidence of healthcare-associated infections is expected to drive the growth of the neutral displacement needles market in the coming years. Healthcare-associated infections are infections acquired by patients while receiving medical care in hospitals, outpatient facilities, nursing homes, and other healthcare environments, and these infections are not present at the time of admission. The prevalence of HAIs continues to increase due to the expanding use of invasive medical devices such as central lines, urinary catheters, and ventilators, which provide direct routes for pathogens to enter the bloodstream. Neutral displacement needleless connectors help reduce this risk by preventing blood reflux into the catheter lumen during disconnection, thereby lowering the possibility of catheter-related bloodstream infections and supporting adherence to infection prevention and control practices. For instance, in January 2026, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, surgical site infections associated with abdominal hysterectomy procedures increased by 8% in 2024 compared to 2023, while nearly 1 in 31 hospitalized patients in the country acquire at least one healthcare-associated infection during their healthcare stay. Therefore, the increasing prevalence of healthcare-associated infections is supporting the growth of the neutral displacement needles market.

The increasing healthcare expenditure is expected to drive the growth of the neutral displacement needles market in the coming years. Healthcare expenditure refers to the overall spending on medical products, healthcare services, public health initiatives, and related activities focused on maintaining or improving health outcomes. Healthcare expenditure is increasing due to the rising burden of chronic diseases, which creates greater demand for long-term therapies, repeated hospital admissions, diagnostic procedures, and continuous medical management. The growth in healthcare expenditure enables healthcare organizations to invest in advanced vascular access devices such as neutral displacement needles, which support infection prevention, enhance patient safety, and improve compliance with established clinical care guidelines. For instance, in April 2025, according to the Office for National Statistics, a UK-based government agency, total non-government healthcare expenditure increased by 1.0% in real terms in 2023, reaching $74 billion (£58.2 billion). Therefore, the increasing healthcare expenditure is contributing to the growth of the neutral displacement needles market.

Major companies operating in the neutral displacement needles market report are Medline Industries LP, Becton Dickinson and Company, ICU Medical Inc., Baxter International Inc., B. Braun Medical Inc., Fresenius Kabi India Private Limited, Teleflex Incorporated, Merit Medical Systems Inc., Vygon (UK) Ltd., Poly Medicure Limited, Amsino International Inc., CODAN US Corporation, Baihe Medical Technology Co. Ltd., Elcam Medical Group, GBUK Group Limited, Harsoria Healthcare Private Limited, NP Medical Inc., Shandong Ande Healthcare Apparatus Co. Ltd., Mediplus (India) Limited, Lars Medicare Private Limited, JCM MED Co. Ltd., MedicalRite, Asset Medical LLC.

North America was the dominant region in the neutral displacement needles market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the neutral displacement needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neutral displacement needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.